Repligen Corp

RGEN: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
b!&LOCK|?&SR>LOCK|p?y>FHK?

Repligen Earnings: Strong Growth and Margin Expansion Despite Filtration and Inflation Headwinds

Repligen reported 12.5% year-on-year organic revenue growth and adjusted EBITDA margin expansion of 1.9 percentage points. Management now expects full-year adjusted EBITDA margin of 21%, at the top of its previous guidance range of 20.6%-21.0%.

Sponsor Center